Insider: Mainolfi Nello Chief Executive Officer - Kymera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 676,431 | 0 | 676,431 |
| Value | $57,767,207.40 | $0.00 | $57,767,207.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/25/2026 | DDS | 19,764 | Direct | COM | $89.78 | $1,774,411.92 | 676,431 |
| 02/25/2026 | DDS | 8 | Direct | COM | $93.49 | $747.92 | 666,195 |
| 02/25/2026 | DDS | 5,434 | Direct | COM | $90.39 | $491,179.26 | 670,997 |
| 02/25/2026 | DDS | 3,293 | Direct | COM | $91.76 | $302,165.68 | 667,704 |
| 02/25/2026 | DDS | 1,501 | Direct | COM | $92.81 | $139,307.81 | 666,203 |
| 12/31/2025 | DDS | 23,986 | Direct | COM | $77.95 | $1,869,727.89 | 669,091 |
| 12/31/2025 | DDS | 6,014 | Direct | COM | $78.52 | $472,211.46 | 663,077 |
| 12/08/2025 | DDS | 100,000 | Direct | COM | $89.17 | $8,917,000.00 | 660,482 |
| 10/29/2025 | DDS | 1,862 | Direct | COM | $59.72 | $111,203.30 | 688,620 |
| 10/29/2025 | DDS | 24,511 | Direct | COM | $61.02 | $1,495,626.90 | 664,109 |
| 10/29/2025 | DDS | 3,627 | Direct | COM | $61.46 | $222,906.72 | 660,482 |
| 09/16/2025 | DDS | 30,000 | Direct | COM | $49.00 | $1,470,000.00 | 660,482 |
| 06/03/2025 | DDS | 30,000 | Direct | COM | $49.00 | $1,470,000.00 | 660,482 |
| 01/12/2022 | DDS | 2,726 | Direct | COM | $51.31 | $139,877.06 | 478,085 |
| 01/12/2022 | DDS | 4,022 | Direct | COM | $52.02 | $209,209.56 | 474,063 |
| 01/12/2022 | DDS | 1,623 | Direct | COM | $53.27 | $86,457.21 | 472,440 |
| 01/12/2022 | DDS | 241 | Direct | COM | $53.97 | $13,006.77 | 472,199 |
| 01/11/2022 | DDS | 9,932 | Direct | COM | $53.68 | $533,109.04 | 479,190 |
| 01/11/2022 | DDS | 6,644 | Direct | COM | $54.42 | $361,582.43 | 472,546 |
| 01/11/2022 | DDS | 347 | Direct | COM | $55.05 | $19,103.36 | 472,199 |
| 01/10/2022 | DDS | 7,485 | Direct | COM | $52.46 | $392,643.64 | 487,179 |
| 01/10/2022 | DDS | 10,673 | Direct | COM | $53.35 | $569,378.93 | 476,506 |
| 01/10/2022 | DDS | 4,201 | Direct | COM | $54.40 | $228,545.32 | 472,305 |
| 01/10/2022 | DDS | 106 | Direct | COM | $54.99 | $5,828.94 | 472,199 |
| 10/11/2021 | DDS | 5,712 | Direct | COM | $53.58 | $306,043.82 | 464,943 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research